We are thrilled to announce a groundbreaking Memorandum of Understanding (MoU) between AGTC Genomics and Pathomics Health to enhance the accessibility and affordability of precision medicine in Malaysia and Southeast Asia.
In an era of advancing medical breakthroughs, we stand at the forefront of a transformative partnership that holds the promise of reshaping healthcare as we know it. This collaboration is built on a shared belief that the benefits of precision medicine should know no bounds. Our mission is clear: to break down the barriers that have limited access to this cutting-edge approach and to usher in an era where precision medicine is not merely a privilege for a select few, but an inalienable right for all.
